CHGA and adenocarcinoma: Five of these tumours expressed chromogranin A in their tumour cells when examined with immunohistochemistry with increased sensitivity by using tyramide signal amplification, which may suggest misclassification of neuroendocrine carcinomas as adenocarcinomas [46].